Company intelligence / Profile preview

Allure Therapeutics

Cambridge, Massachusetts, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Allure Therapeutics is a Cambridge-based biotechnology company focused on developing transformative therapies for neurodegenerative diseases. The company leverages a proprietary platform to discover and develop small molecule allostatic modulators that restore protein homeostasis, with a lead focus on the GBA1 pathway. Backed by Atlas Venture, Allure is targeting high-impact conditions such as Parkinson's disease and Gaucher disease. The company is currently in the pre-clinical stage, building a robust pipeline of disease-modifying treatments.

Therapeutic areas: NeurologyRare Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Allure Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allure Therapeutics.

Explore the full profile